NCT03948542 is a clinical trial of Outcome in Radial Nerve Palsy, sponsored by Medical University of Vienna.

Who is sponsoring NCT03948542?

NCT03948542 is sponsored by Medical University of Vienna.

What drugs are being tested in NCT03948542?

Interventions in NCT03948542: Outcome.

What condition does NCT03948542 study?

NCT03948542 studies Radial Nerve Palsy, Functional Outcome.

Is NCT03948542 still recruiting?

NCT03948542 is currently completed. Last updated 17 May 2019.

Last reviewed 2019-05-17 · How we verify

NCT03948542

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fractures of the Humeral Shaft With Primary Radial Nerve Palsy

Completed Last updated 17 May 2019

What this trial tests

trial testing Outcome in Radial Nerve Palsy in 50 participants. Completed in 1 March 2015.

Timeline

1 January 2014

Primary endpoint
1 January 2015

1 March 2015

Quick facts

Lead sponsor	Medical University of Vienna
Status	Completed
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 January 2014
Primary completion	1 January 2015
Estimated completion	1 March 2015

Drugs / interventions tested

Outcome

Conditions studied

Radial Nerve Palsy — all drugs for Radial Nerve Palsy →
Functional Outcome — all drugs for Functional Outcome →

Sponsor

Medical University of Vienna

Who can join

18 and older, any sex, with Radial Nerve Palsy or Functional Outcome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study addresses the question if patients with fractures of the humeral shaft and primary radial nerve palsy gain nerve recovery. Additionally the influence of injury mechanism, fracture type, and treatment modality on nerve recovery should be evaluated.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Fractures of the Humeral Shaft with Primary Radial Nerve Palsy: Do Injury Mechanism, Fracture Type, or Treatment Influence Nerve Recovery?
Ostermann RC, Lang NW, Joestl J, Pauzenberger L, et al · · 2019 · cited 6× · PMID 31739459 · DOI 10.3390/jcm8111969

Verify or expand the search:

Other trials of Outcome

Trials testing the same drug.

NCT05338593 — Therapy and Outcome of Prolonged Veno-venous ECMO Therapy of Critically Ill ARDS Patients. · completed
NCT04689334 — General Surgery Residency Training in Low Income Countries · completed

Other Medical University of Vienna trials

Trials by the same sponsor.

NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03948542 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
Last refreshed: 17 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03948542.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing